Cite
Synthesis of nucleosidyl rifamycins as inhibitors of human immunodeficiency virus type 1
MLA
C. Bartolucci, et al. Synthesis of Nucleosidyl Rifamycins as Inhibitors of Human Immunodeficiency Virus Type 1. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6cbaf633e430b6686c7f96ccc2074b2d&authtype=sso&custid=ns315887. Accessed 13 Feb. 2025.
APA
C. Bartolucci, Vittorio Brizzi, L. Cellai, Luisa Mannina, Luigi Filocamo, A. Di Caro, M. Marzano, Arrigo Benedetto, Mario Brufani, & Samantha Messina. (n.d.). Synthesis of nucleosidyl rifamycins as inhibitors of human immunodeficiency virus type 1.
Chicago
C. Bartolucci, Vittorio Brizzi, L. Cellai, Luisa Mannina, Luigi Filocamo, A. Di Caro, M. Marzano, Arrigo Benedetto, Mario Brufani, and Samantha Messina. 2025. “Synthesis of Nucleosidyl Rifamycins as Inhibitors of Human Immunodeficiency Virus Type 1.” Accessed February 13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6cbaf633e430b6686c7f96ccc2074b2d&authtype=sso&custid=ns315887.